![Be Careful What You Advertise](https://pharmacyconsulting.co.uk/wp-content/uploads/2024/07/Advertise.jpg)
Be Careful What You Advertise
Most of us will know that it is illegal to promote prescription only medicines (POMs) to members of the public, however, it is always worth a reminder that you must be careful what you advertise.
Most of us will know that it is illegal to promote prescription only medicines (POMs) to members of the public, however, it is always worth a reminder that you must be careful what you advertise.
Self-Inspections are an important part of GDP and ensuring you keep your activities and licence compliant.
Those companies manufacturing and handling medical devices should be aware that there are changes to the UK regulatory environment coming.
The MHRA have made the first release of their RegulatoryConnect service available which allows tracking of the submission status of product licence applications but will soon offer much more.
The Medicines and Healthcare products Regulatory Agency (MHRA) announced that from the 31st of January 2024 new regulatory measures have been implemented to ensure that the known harms associated with valproate use are reduced.
The MHRA is the first Regulatory body in the world to authorise a Crispr-based gene therapy.